Search results
Results from the WOW.Com Content Network
Advanced Bio-Treatment (ABT) is a biohazard response and remediation company operating in twenty-eight states. The company employs a multitude of cleanup teams specializing in crime scene cleanup . Day-to-day business operations are overseen by a customer service driven team from the company’s corporate office located in Jacksonville, Florida .
Fuad El-Hibri (deceased, April 23, 2022), the founder of the company and former CEO, [33] led the company since its founding as BioPort Inc. [34] [35] until his retirement on April 1, 2012. [36] [37] El-Hibri continued to serve as the executive chairman of Emergent BioSolutions' board of directors until shortly before his death in 2022. [38]
In 2020, Amyris received Bonsucro's Chain of Custody Certification, ensuring that the sustainability claims along the sugarcane supply chain are traceable from farmer to end user. [11] During the COVID-19 pandemic , the company collaborated with the Infectious Disease Research Institute (IDRI) to advance a novel ribonucleic acid (RNA) vaccine ...
1. Go to the comment you are reporting. 2. Select the Drop-Down Arrow on the far right-hand corner of the text-box. 3. Click report. If you come across an article with inappropriate or incorrect information, please let us know by submitting a feedback form.
Emergent has been delivering Cyfendus to the U.S. Department of Health and Human Services since 2019, under pre-emergency use authorization status, and will continue to work with the U.S ...
PE Biosystems Group was renamed once again to Applied Biosystems Group, and changed its ticker symbol from PEB to ABI. Its net revenues rose to almost US$1.4 billion. [ 23 ] Celera that year made milestone headlines when it announced that it had completed the sequencing and first assembly of the two largest genomes in history, that of the fruit ...
In August 2016, company acquired Advanced Cell Diagnostics for $250 million plus an additional $75 million in possible milestone payments. [21] [22] [23] In September 2017, the company acquired Trevigen. [24] [25] In January 2018, the company acquired Atlanta Biologicals. [26] [27] In June 2018, the company agreed to acquire Quad Technologies ...
On June 1, 2006, the DHHS awarded a $363 million contract to Emergent BioSolutions, (then Cangene Corporation) for 200,000 doses of BAT over five years for delivery into the US Strategic National Stockpile (SNS). [10] The CDC began supplying doses to the SNS in 2007 under a now $427 million contract with the DHHS, according to a Cangene press ...